Data for: A phase II, multicenter, single-arm trial of eribulin as first-line therapy for aggressive taxane-pretreated HER2-negative metastatic breast cancer patients: The MERIBEL study
收藏Mendeley Data2019-01-09 更新2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/ffg8fv5ph5
下载链接
链接失效反馈官方服务：
资源简介：
A phase II, multicenter, single-arm trial of eribulin as first-line therapy for aggressive taxane-pretreated HER2-negative metastatic breast cancer patients: The MERIBEL study
一项针对经紫杉类药物预处理的侵袭性人类表皮生长因子受体2（HER2）阴性转移性乳腺癌患者、将艾瑞布林（Eribulin）作为一线治疗方案的Ⅱ期多中心单臂临床试验：MERIBEL研究
创建时间：
2019-01-09
